Skip to main content

Methodological development in medical technology assessment: the prospective approach

Buy Article:

$47.50 plus tax (Refund Policy)

Risks associated with modern drugs expand and develop beyond our existing control and perception mechanisms. New medicines have the ability to transform side effects from the traditional individual physical level to a societal level in the form of economic, political and ethical consequences. Existing assessment methods cannot capture or cope with the side effects we will experience with tomorrow's drugs. We interpret this as a sign of the need for on-going methodological developments within Medical Technology Assessment (MTA) to capture and include the as yet 'unknown' and 'unforeseen' economic, political and ethical risks of modern drugs. In this paper, we argue that a propsective inter-disciplinary approach should be applied to MTA as a form of 'early warning system', using the Delphi method combined with prospective scenarios to keep up with the changing characteristics of new drugs.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: HTA; MTA; early warning; future; medicine; prospective; technology assessment

Document Type: Research Article

Affiliations: 1: The Royal Danish School of Pharmacy, Department of Social Pharmacy, Universitetsparken 2, DK-2100 Copenhagen 2: Institute for Alternative Futures, 100 N. Pitt Street Suite 235, Alexandria, VA 22314

Publication date: 2003-03-01

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more